NGS-based RNA-sequencing Market Overview
The NGS-based RNA-sequencing Market is experiencing substantial growth, driven by technological advancements, expanding applications in genomics and transcriptomics, and the increasing focus on personalized medicine. Next-generation sequencing technologies are enabling comprehensive RNA analysis, supporting gene expression studies, biomarker discovery, drug development, and emerging clinical applications.
According to the latest Market Research Future report, updated June 08, 2026, the NGS-based RNA-sequencing Market was valued at USD 3.2 billion in 2024 and is projected to grow from USD 3.872 billion in 2025 to USD 26.05 billion by 2035, registering a CAGR of 21.0% during the forecast period 2025–2035. North America remains the largest regional market, while Asia-Pacific is emerging as the fastest-growing region. Sequencing Services hold the largest position among product and service categories, while Sample Preparation Products are experiencing the fastest growth.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.marketresearchfuture.com/sample_request/22119
Key players driving innovation and competitiveness in the NGS-based RNA-sequencing Market include:
Illumina
Thermo Fisher Scientific
Roche
Qiagen
PerkinElmer
BGI
Agilent Technologies
Oxford Nanopore Technologies
Macrogen
The NGS-based RNA-sequencing Market is being propelled by collaborative research initiatives, rising demand for biomarker discovery, and increasing adoption of personalized medicine. Growing investments in genomic research and high-throughput sequencing are expanding the use of RNA-sequencing technologies across research, drug development, and clinical diagnostics. Continuous improvements in sequencing accuracy, speed, cost-effectiveness, and data analysis are also supporting wider adoption.
The NGS-based RNA-sequencing Market can be segmented by Product and Service, Technology, Application, End-User, and Region. By Product and Service, the market includes Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, and Data Analysis, Storage and Management, with Sequencing Services holding the largest share and Sample Preparation Products identified as the fastest-growing segment. By Technology, Sequencing by Synthesis (SBS) dominates, while Ion Semiconductor Sequencing is emerging rapidly. By Application, Expression Profiling Analysis leads, while Small RNA Sequencing is the fastest-growing application. By End-User, Pharmaceutical and Biotechnology Companies dominate, while Hospitals and Clinics are experiencing rapid growth.
Significant opportunities are emerging from advancements in bioinformatics tools, rising demand for biomarker discovery, and the expansion of personalized medicine. Integrated platforms for RNA-sequencing data analysis, increasing sequencing services in emerging markets, and partnerships between sequencing providers and pharmaceutical companies for drug discovery are expected to create further growth opportunities. The increasing volume of sequencing data is also creating demand for advanced storage, management, and cloud-based analysis solutions.
Recent Developments and Market Trends:
Technological advancements are improving sequencing accuracy, throughput, efficiency, and cost-effectiveness, supporting broader adoption across research and clinical applications.
The growing emphasis on personalized medicine is increasing demand for RNA-sequencing technologies capable of providing detailed insights into individual genetic profiles and disease mechanisms.
Collaborative research initiatives between academic institutions, healthcare organizations, and biotechnology companies are accelerating innovation and the translation of research findings into clinical applications.
Demand for biomarker discovery is increasing as pharmaceutical companies and research institutions use RNA sequencing to identify biomarkers for disease detection, prognosis, and treatment monitoring.
Clinical diagnostic applications are expanding, particularly in oncology, genetic disorders, and infectious diseases, as healthcare providers increasingly adopt NGS technologies.
Reasons to Buy the Report:
Gain detailed insights into the global NGS-based RNA-sequencing Market size, growth trajectory, and forecast through 2035.
Understand major market segments across product and service, technology, application, and end-user categories.
Evaluate the competitive landscape and strategic initiatives of leading companies operating in the NGS-based RNA-sequencing Market.
Analyze key market drivers, technological developments, emerging trends, and growth opportunities.
Assess regional market dynamics and identify opportunities across North America, Europe, Asia-Pacific, and the Rest of the World.
Future Outlook:
The NGS-based RNA-sequencing Market is projected to grow at a CAGR of 21.0% from 2025 to 2035, reaching USD 26.05 billion by 2035. North America is expected to retain its leading position due to well-established healthcare infrastructure, high healthcare spending, strong biopharmaceutical activity, and demand for personalized treatment approaches. Asia-Pacific is anticipated to remain the fastest-growing region, supported by increasing investments in genomic research, healthcare infrastructure, and personalized medicine. Sequencing Services are expected to maintain their leading position within the product and service segment, while Sample Preparation Products are positioned for rapid growth. Sequencing by Synthesis (SBS) is expected to remain the dominant technology, with the segment projected to reach USD 12.5 billion by 2035. Expression Profiling Analysis is likely to continue leading applications, while Small RNA Sequencing gains momentum. Pharmaceutical and Biotechnology Companies are expected to remain the dominant end-user segment, reaching USD 13.25 billion by 2035, while Hospitals and Clinics continue expanding their use of NGS for clinical diagnostics and precision medicine. Overall, advancements in sequencing technologies, bioinformatics, biomarker discovery, collaborative research, and personalized healthcare are expected to support the market’s strong expansion through 2035.
➤➤Explore Our Latest Related Reports:
